Norman Fields Gottscho Capital Management’s AbbVie ABBV Stock Holding History

Norman Fields Gottscho Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$899K	Hold	3,573	–	–	0.27%	36
2026 Q1	$777K	Hold	3,573	–	–	0.26%	38
2025 Q4	$816K	Sell	3,573 -33	-0.9%	-$7.52K	0.26%	39
2025 Q3	$835K	Hold	3,606	–	–	0.27%	38
2025 Q2	$669K	Hold	3,606	–	–	0.22%	39
2025 Q1	$756K	Sell	3,606 -642	-15%	-$125K	0.25%	39
2024 Q4	$755K	Hold	4,248	–	–	0.25%	38
2024 Q3	$839K	Hold	4,248	–	–	0.28%	38
2024 Q2	$714K	Buy	4,248 +33	+0.8%	+$5.47K	0.25%	39
2024 Q1	$768K	Sell	4,215 -33	-0.8%	-$5.69K	0.29%	40
2023 Q4	$658K	Hold	4,248	–	–	0.26%	41
2023 Q3	$633K	Hold	4,248	–	–	0.27%	44
2023 Q2	$572K	Sell	4,248 -740	-15%	-$109K	0.24%	44
2023 Q1	$795K	Hold	4,988	–	–	0.35%	39
2022 Q4	$806K	Hold	4,988	–	–	0.37%	38
2022 Q3	$669K	Hold	4,988	–	–	0.32%	42
2022 Q2	$764K	Hold	4,988	–	–	0.35%	42
2022 Q1	$809K	Hold	4,988	–	–	0.3%	46
2021 Q4	$675K	Hold	4,988	–	–	0.25%	53
2021 Q3	$538K	Sell	4,988 -100	-2%	-$11.4K	0.21%	49
2021 Q2	$573K	Sell	5,088 -120	-2%	-$13.5K	0.23%	48
2021 Q1	$564K	Sell	5,208 -187	-3%	-$20K	0.25%	48
2020 Q4	$578K	Sell	5,395 -85	-2%	-$8.17K	0.26%	39
2020 Q3	$480K	Sell	5,480 -1,025	-16%	-$96.5K	0.24%	43
2020 Q2	$639K	Sell	6,505 -570	-8%	-$50.2K	0.35%	37
2020 Q1	$539K	Sell	7,075 -5,740	-45%	-$489K	0.34%	39
2019 Q4	$1.14M	Sell	12,815 -65	-0.5%	-$5.4K	0.55%	32
2019 Q3	$975K	Sell	12,880 -240	-2%	-$16.5K	0.49%	37
2019 Q2	$954K	Hold	13,120	–	–	0.48%	39
2019 Q1	$1.06M	Hold	13,120	–	–	0.56%	36
2018 Q4	$1.21M	Hold	13,120	–	–	0.71%	34
2018 Q3	$1.24M	Hold	13,120	–	–	0.62%	37
2018 Q2	$1.22M	Hold	13,120	–	–	0.65%	36
2018 Q1	$1.24M	Hold	13,120	–	–	0.68%	35
2017 Q4	$1.27M	Hold	13,120	–	–	0.7%	34
2017 Q3	$1.17M	Hold	13,120	–	–	0.7%	34
2017 Q2	$951K	Sell	13,120 -214	-2%	-$14.4K	0.6%	35
2017 Q1	$869K	Hold	13,334	–	–	0.55%	36
2016 Q4	$835K	Hold	13,334	–	–	0.57%	37
2016 Q3	$841K	Hold	13,334	–	–	0.56%	40
2016 Q2	$826K	Hold	13,334	–	–	0.58%	36
2016 Q1	$762K	Hold	13,334	–	–	0.51%	39
2015 Q4	$790K	Hold	13,334	–	–	0.56%	38
2015 Q3	$726K	Hold	13,334	–	–	0.5%	41
2015 Q2	$896K	Hold	13,334	–	–	0.56%	38
2015 Q1	$781K	Hold	13,334	–	–	0.49%	42
2014 Q4	$873K	Hold	13,334	–	–	0.57%	36
2014 Q3	$770K	Hold	13,334	–	–	0.51%	43
2014 Q2	$753K	Hold	13,334	–	–	0.48%	41
2014 Q1	$685K	Hold	13,334	–	–	0.47%	41
2013 Q4	$704K	Hold	13,334	–	–	0.47%	39
2013 Q3	$596K	Hold	13,334	–	–	0.45%	44
2013 Q2	$551K	Buy	+13,334	New	+$583K	0.41%	48

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Norman Fields Gottscho Capital Management's ABBV Position: Q2 2026 in Review

Norman Fields Gottscho Capital Management held its AbbVie (ABBV) position steady in Q2 2026 at 3,573 shares worth $899K. The position accounts for 0.27% of the portfolio, ranked #36.

Norman Fields Gottscho Capital Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.27M in Q4 2017. 921 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Norman Fields Gottscho Capital Management held 3,573 shares of AbbVie worth $899K as of Q2 2026.
Norman Fields Gottscho Capital Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.27% of Norman Fields Gottscho Capital Management's portfolio in Q2 2026, its #36 holding.
Norman Fields Gottscho Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
Norman Fields Gottscho Capital Management's AbbVie position peaked at $1.27M in Q4 2017.
921 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Norman Fields Gottscho Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.